Skip to main content
Erschienen in: Allergo Journal 6/2020

21.09.2020 | Anaphylaxie | AeDA/DGAKI informieren

Weisheiten aus dem Weißbuch - Kapitel 3.12

Rund um Arzneimittelüberempfindlichkeiten

verfasst von: Prof. Dr. med. Knut Brockow, PD Dr. Hagen Ott, Prof. Dr. med. Bernhard Przybilla

Erschienen in: Allergo Journal | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Auszug

Kapitel 3.12 der Neuauflage des "Weißbuch Allergie in Deutschland" von Knut Brockow, Hagen Ott und Bernhard Przybilla befasst sich mit Arzneimittelüberempfindlichkeiten. Auslöser und Mechanismen werden beleuchtet, diagnostische Möglichkeiten vorgestellt und Defizite bei der Versorgung der Patienten benannt.
Literatur
1.
Zurück zum Zitat Brockow K. Drug Allergy: Definitions and Phenotypes. In: Khan DA, Banerji A (eds). Drug Allergy Testing. St. Louis, USA: Elsevier; 2018: 19-26 Brockow K. Drug Allergy: Definitions and Phenotypes. In: Khan DA, Banerji A (eds). Drug Allergy Testing. St. Louis, USA: Elsevier; 2018: 19-26
2.
Zurück zum Zitat Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Soci-ety (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environ-mental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015;24:94-105 Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Soci-ety (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environ-mental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015;24:94-105
3.
Zurück zum Zitat Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy 2014;69:420-37 Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy 2014;69:420-37
4.
Zurück zum Zitat Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16 Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005;5:309-16
5.
Zurück zum Zitat Pichler WJ. Drug Hypersensitivity. Basel: Karger, 2007. Pichler WJ. Drug Hypersensitivity. Basel: Karger, 2007.
6.
Zurück zum Zitat Paulmann M, Mockenhaupt M. Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges 2015;13:625-45 Paulmann M, Mockenhaupt M. Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges 2015;13:625-45
7.
Zurück zum Zitat Schnyder B, Brockow K. Pathogenesis of drug allergy - current concepts and recent insights. Clin Exp Allergy 2015;45: 1376-83 Schnyder B, Brockow K. Pathogenesis of drug allergy - current concepts and recent insights. Clin Exp Allergy 2015;45: 1376-83
8.
Zurück zum Zitat Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139: 683-93 Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139: 683-93
9.
Zurück zum Zitat Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, et al. IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015;136:685-91 Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, et al. IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015;136:685-91
10.
Zurück zum Zitat Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, Bircher A et al. Management of hypersensitivity reactions to io-dinated contrast media. Allergy 2005;60:150-58 Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, Bircher A et al. Management of hypersensitivity reactions to io-dinated contrast media. Allergy 2005;60:150-58
11.
Zurück zum Zitat Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The Euro-SCAR-study. J Invest Dermatol 2008;128:35-44 Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The Euro-SCAR-study. J Invest Dermatol 2008;128:35-44
12.
Zurück zum Zitat Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63 Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63
13.
Zurück zum Zitat Brockow K, Aberer W, Atanaskovic-Markovic M, S Bavbek 4, A Bircher 5, B Biloet al. Drug allergy passport and other docu-mentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy 2016;71:1533-9 Brockow K, Aberer W, Atanaskovic-Markovic M, S Bavbek 4, A Bircher 5, B Biloet al. Drug allergy passport and other docu-mentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy 2016;71:1533-9
14.
Zurück zum Zitat Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-12 Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-12
15.
Zurück zum Zitat Demoly P, Kropf R, Pichler WJ, Bircher A. Drug hypersensitivity questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999;54:999-1003 Demoly P, Kropf R, Pichler WJ, Bircher A. Drug hypersensitivity questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999;54:999-1003
16.
Zurück zum Zitat Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016;71:149-61 Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016;71:149-61
17.
Zurück zum Zitat Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2016;71:1103-34 Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2016;71:1103-34
Metadaten
Titel
Weisheiten aus dem Weißbuch - Kapitel 3.12
Rund um Arzneimittelüberempfindlichkeiten
verfasst von
Prof. Dr. med. Knut Brockow
PD Dr. Hagen Ott
Prof. Dr. med. Bernhard Przybilla
Publikationsdatum
21.09.2020
Verlag
Springer Medizin
Erschienen in
Allergo Journal / Ausgabe 6/2020
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-020-2589-z

Weitere Artikel der Ausgabe 6/2020

Allergo Journal 6/2020 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.